COMMUNIQUÉS West-GlobeNewswire

Organovo Partners With IIAM on Multi-Year Clinical Biomaterial Sourcing Agreement

12/11/2018 - 14:05

SAN DIEGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]

Novan Announces Corporate Update Conference Call and Webcast

12/11/2018 - 14:05

MORRISVILLE, N.C., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company will host a conference call on Wednesday, November 14, at 8:30 a.m. Eastern Time [...]

Hospital for Special Care expands and extends relationship with Allscripts; Allscripts Sunrise helps Autism Center and COPD Disease Management programs earn first in nation Patient Centered Specialty Practice recognition for program types

12/11/2018 - 14:01

Not-for-profit hospital extends and further expands portfolio to include integrated registration, scheduling tools and medication management solutions CHICAGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX [...]

Matrix Medical Network Recognizes National Nurse Practitioner Week

12/11/2018 - 14:00

SCOTTSDALE, Ariz., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) is recognizing nurse practitioners nationwide and within our own clinical teams during National Nurse Practitioner Week, November 11- [...]

HTG Molecular Presenting at Upcoming Healthcare Conferences

12/11/2018 - 14:00

TUCSON, Ariz., Nov. 12, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ [...]

Cocrystal Pharma Reports 2018 Third Quarter Financial Results and Provides Corporate Update

12/11/2018 - 14:00

BOTHELL, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that [...]

Immutep Presents Positive New Data from Ongoing TACTI-mel Study at Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting

12/11/2018 - 14:00

SYDNEY, Australia, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

PotNetwork Holding's Diamond CBD Presented Chong’s Choice, Showcased at the Las Vegas Convention Center, at the Recent 2018 CBD.io in Collaboration With VAPEXPO Event Held November 9th and 10th

12/11/2018 - 14:00

Company Joined the Biggest Names in Vape and Hemp for an Epic Collaboration of Two Swiftly Growing Industries Fort Lauderdale, Fla., Nov. 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holdings, Inc. (OTC [...]

HempAmericana Commences Processing Hemp Flower at CBD Production Facility

12/11/2018 - 14:00

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce that it has begun processing 4,100 lbs of in-house Hemp Flower [...]

Coherus BioSciences Management to Present at the 27th Annual Credit Suisse Healthcare Conference

12/11/2018 - 14:00

REDWOOD CITY, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will be presenting at the 27th Annual Credit Suisse Healthcare Conference being [...]

Palvella Therapeutics Announces FDA Fast Track Designation for PTX-022 for Treatment of Pachyonychia Congenita

12/11/2018 - 14:00

Wayne, PA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically targeted therapies for debilitating genetic [...]

Aleafia to Release Q3 Results on Nov 26, Hold First Ever Results Call

12/11/2018 - 13:48

TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “ Company “), a highly differentiated cannabis company with major cannabis cultivation and [...]

Transactions under Novozymes’ stock buyback program

12/11/2018 - 13:38

Please read the full announcement in the attached PDF Attachment 2018_63_Stock_Buybackprogram_EN

Apotheca Biosciences (PCFP) Plans Uplisting to OTCQB

12/11/2018 - 13:30

SAINT PETERSBURG, FL, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]

Pain Therapeutics Appeals FDA Decision on REMOXY

12/11/2018 - 13:30

AUSTIN, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that it has petitioned the Food & Drug Administration (FDA) regarding a Complete [...]

MyoKardia Presents Preclinical Evidence of Mavacamten’s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions

12/11/2018 - 13:30

Improved Left Ventricular Compliance Demonstrated in Genetic Pig Model of Non-Obstructed Hypertrophic Cardiomyopathy Results Add to Growing Body of Evidence of Mavacamten’s Dual Activity in Increasing Compliance and [...]

New Findings from Pluristem’s Phase II IC study: PLX-PAD Cells Significantly Improves Blood Glucose Control (HbA1c) and Reduce Chronic Inflammation

12/11/2018 - 13:30

Additional data from Pluristem’s Phase II IC study were presented at the 2018 American Heart Association Scientific Sessions HAIFA, Israel, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) ( [...]

Auxly Reports Q3 2018 Financial Results and Highlights Key Milestones

12/11/2018 - 13:30

VANCOUVER, British Columbia, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") has reported its financial and operational results for the three and [...]

Collegium to Present at Upcoming Investor Conferences

12/11/2018 - 13:24

STOUGHTON, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company focused on becoming the leader in responsible pain management by developing and [...]